Key Factors Fueling the Growth of the Percutaneous Mechanical Circulatory Support Devices Market in 2025: Rising Cardiovascular Disease Incidence Driving Growth In The Market
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Percutaneous Mechanical Circulatory Support Devices Market’s Growth Trajectory From 2025 To 2034?
Over recent years, the market size for percutaneous mechanical circulatory support devices has seen significant growth. Expansion is projected to continue, with an increase from $2.26 billion in 2024 to $2.46 billion in 2025, representing a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this historic period of growth include a rise in cardiovascular disease cases, a growing older population, an increase in heart attack occurrences, heightened awareness and screening programs, and a heightened demand for heart pump devices.
The market for percutaneous mechanical circulatory support devices is predicted to witness significant growth in the upcoming years and is estimated to reach $3.55 billion by 2029, expanding at a compound annual growth rate (CAGR) of 9.5%. This growth over the forecast period can be associated with an increase in requirements for long-term mechanical circulatory support, a surge in health care spending, a growing number of diabetics and obese individuals, a rising demand for heart transplants, and increased acceptance of percutaneous procedures. Key trends anticipated during this forecast period consist of developments in pump technology, progress in medical technology, cardiac support technologies, minimally invasive medical technologies, and the production of biocompatible materials.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp
What are the Fundamental Drivers and Innovations Shaping the Percutaneous Mechanical Circulatory Support Devices Market?
The escalating prevalence of cardiovascular ailments is poised to stimulate the expansion of the percutaneous mechanical circulatory support devices market. Cardiovascular diseases (CVDs), which encompass a range of disorders impacting the heart and blood vessels such as coronary artery disease, heart attacks, heart failure, stroke, and hypertension, are on the rise due to a plethora of factors. This includes an aging demographic, unhealthy lifestyle habits, obesity, high blood pressure, and a genetic susceptibility. Percutaneous mechanical circulatory support devices come into play in cardiovascular disease scenarios to enhance cardiac performance, alleviate heart strain, and foster recovery during severe heart complications. For example, data from the Australian Institute of Health and Welfare in December 2023, an Australian government body, showed an increase in doctor-certified deaths from coronary heart disease (CHD) to 14,100 in 2021 and a surge to 14,900 in 2022. Consequently, this rising prevalence of cardiovascular diseases is fueling the growth of the percutaneous mechanical circulatory support (MCS) devices market.
How Is the Percutaneous Mechanical Circulatory Support Devices Market Segmented?
The percutaneous mechanical circulatory support devicesmarket covered in this report is segmented –
1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types
2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices
2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)
3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)
4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System
5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp
Which Regions Are Driving the Next Phase of the Percutaneous Mechanical Circulatory Support Devices Market Growth?
North America was the largest region in the percutaneous mechanical circulatory support devices market in 2024. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Percutaneous Mechanical Circulatory Support Devices Market?
Leading firms in the percutaneous mechanical circulatory support devices market are concentrating on the creation of cutting-edge solutions like intra-aortic axial-flow devices to heighten patient results and cut down on surgical risks. Intra-aortic axial-flow devices are a kind of percutaneous mechanical circulatory support (MCS) tool, developed to boost heart performance by augmenting the blood transmission from the left ventricle to the aorta. For instance, in February 2023, US-based medical device firm, Procyrion, Inc, unveiled the successful maiden human application of their Aortix pump. This trailblazing gadget is engineered to ward off acute kidney injury (AKI) in patients getting cardiac surgery. Positioned through a catheter in the descending thoracic aorta, the Aortix pump uplifts kidney perfusion while minimizing the heart’s effort during surgery. It accomplishes this by simultaneously amplifying renal and systemic perfusion, and lessening stress on the heart, making it particularly useful for individuals with weakened left ventricular function and kidney problems. The Aortix pump, which is capable of administering up to 5.0 liters of flow per minute, is planned for transitory use during operations like percutaneous coronary interventions (PCI).
View the full report here:
How Is the Percutaneous Mechanical Circulatory Support Devices Market Defined and What Are Its Core Parameters?
Percutaneous mechanical circulatory support (pMCS) devices are minimally invasive systems used to temporarily assist or completely replace the pumping function of the heart. These devices are inserted through a catheter into blood vessels, typically via the femoral artery, and positioned in the heart to provide mechanical support during acute heart failure, cardiogenic shock, or high-risk cardiac interventions.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20921
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
